{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T00:52:49Z","timestamp":1794444769548,"version":"4.9.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100001245","name":"Jeffrey Modell Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001245","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bubble Foundation"},{"name":"Society for the Relief of Disabled Children in Hong Kong"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10875-024-01829-z","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T23:59:45Z","timestamp":1731542385000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Outcomes of X-Linked Agammaglobulinaemia Patients"],"prefix":"10.1007","volume":"45","author":[{"given":"Ben","family":"Shillitoe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime S. Rosa","family":"Duque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie H. Y.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsun Ming","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery C. H.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Bourne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Stroud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry","family":"Flood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Buckland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winnie","family":"Ip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austen","family":"Worth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Hackett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Herwadkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Coulter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Blaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Jolles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomaz","family":"Garcez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Moya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saul","family":"Faust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Lung","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Gennery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,14]]},"reference":[{"key":"1829_CR1","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1542\/peds.9.6.722","volume":"9","author":"OC Bruton","year":"1952","unstructured":"Bruton OC. Agammaglobulinemia Pediatr. 1952;9:722\u20138.","journal-title":"Agammaglobulinemia Pediatr"},{"key":"1829_CR2","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/eji.1830010615","volume":"1","author":"FP Siegal","year":"1971","unstructured":"Siegal FP, Pernis B, Kunkel HG. Lymphocytes in human immunodeficiency states: a study of membrane-associated immunoglobulins. Eur J Immunol. 1971;1:482\u20136.","journal-title":"Eur J Immunol"},{"key":"1829_CR3","first-page":"513","volume":"69","author":"MD Cooper","year":"1972","unstructured":"Cooper MD, Lawton AR. Circulating B-cells in patients with immunodeficiency. Am J Pathol. 1972;69:513\u201328.","journal-title":"Am J Pathol"},{"key":"1829_CR4","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1172\/JCI107354","volume":"52","author":"RS Geha","year":"1973","unstructured":"Geha RS, Rosen FS, Merler E. Identification and characterization of subpopulations of lymphocytes in human peripheral blood after Fractionation on Discontinuous gradients of Albumin: the Cellular defect in X-Linked agammaglobulinaemia. J Clin Invest. 1973;52:1726\u201334.","journal-title":"J Clin Invest"},{"key":"1829_CR5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0090-1229(73)90025-1","volume":"1","author":"JL Preud\u2019Homme","year":"1973","unstructured":"Preud\u2019Homme JL, Griscelli C, Seligmann M. Immunoglobulins on the surface of lymphocytes in fifty patients with primary immunodeficiency diseases. Clin Immunol Immunopathol. 1973;1:241\u201356.","journal-title":"Clin Immunol Immunopathol"},{"key":"1829_CR6","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.4049\/jimmunol.120.4.1169","volume":"120","author":"ER Pearl","year":"1978","unstructured":"Pearl ER, Vogler LB, Okos AJ, Crist WM, Lawton AR, Cooper MD. B lymphocyte precursors in human bone marrow: an analysis of normal individuals and patients with Antibody-Deficiency States. J Immunol. 1978;120:1169\u201375.","journal-title":"J Immunol"},{"key":"1829_CR7","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/0092-8674(93)90667-F","volume":"72","author":"S Tsukada","year":"1993","unstructured":"Tsukada S, Saffran DC, Rawlings DJ, Parolini O, Allen RC, Klisak I, et al. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell. 1993;72:279\u201390.","journal-title":"Cell"},{"key":"1829_CR8","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/361226a0","volume":"361","author":"D Vetrie","year":"1993","unstructured":"Vetrie D, Vorechovsk\u00fd I, Sideras P, Holland J, Davies A, Flinter F, et al. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature. 1993;361:226\u201333.","journal-title":"Nature"},{"key":"1829_CR9","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1002\/eji.1830241228","volume":"24","author":"HC Genevier","year":"1994","unstructured":"Genevier HC, Hinshelwood S, Gaspar HB, Rigley KP, Brown D, Saeland S, et al. Expression of Bruton\u2019s tyrosine kinase protein within the B cell lineage. Eur J Immunol. 1994;24:3100\u20135.","journal-title":"Eur J Immunol"},{"key":"1829_CR10","doi-asserted-by":"publisher","first-page":"557","DOI":"10.4049\/jimmunol.152.2.557","volume":"152","author":"CI Smith","year":"1994","unstructured":"Smith CI, Baskin B, Humire-Greiff P, Zhou JN, Olsson PG, Maniar HS, et al. Expression of Bruton\u2019s agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells. J Immunol. 1994;152:557\u201365.","journal-title":"J Immunol"},{"key":"1829_CR11","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/j.0105-2896.2005.00233.x","volume":"203","author":"ME Conley","year":"2005","unstructured":"Conley ME, Broides A, Hernandez-Trujillo V, Howard V, Kanegane H, Miyawaki T, et al. Genetic analysis of patients with defects in early B-cell development. Immunol Rev. 2005;203:216\u201334.","journal-title":"Immunol Rev"},{"key":"1829_CR12","unstructured":"Abbas AK, Lichtman AH. Pillai Shiv. Cellular and molecular immunology. Saunders\/Elsevier; 2017."},{"key":"1829_CR13","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1007\/BF00918361","volume":"2","author":"B Pirofsky","year":"1982","unstructured":"Pirofsky B, Campbell SM, Montanaro A. Individual patient variations in the kinetics of intravenous immune globulin administration. J Clin Immunol. 1982;2:S7\u201314.","journal-title":"J Clin Immunol"},{"key":"1829_CR14","first-page":"1","volume":"76","author":"ND Garbett","year":"1989","unstructured":"Garbett ND, Currie DC, Cole PJ. Comparison of the clinical efficacy and safety of an intramuscular and an intravenous immunoglobulin preparation for replacement therapy in idiopathic adult onset panhypogammaglobulinaemia. Clin Exp Immunol. 1989;76:1\u20137.","journal-title":"Clin Exp Immunol"},{"key":"1829_CR15","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/j.jaci.2009.09.046","volume":"125","author":"HW Schroeder","year":"2010","unstructured":"Schroeder HW, Cavacini L. Structure and function of immunoglobulins. J Allergy Clin Immunol. 2010;125:S41\u201352.","journal-title":"J Allergy Clin Immunol"},{"key":"1829_CR16","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.0105-2896.2005.00290.x","volume":"206","author":"JM Woof","year":"2005","unstructured":"Woof JM, Mestecky J. Mucosal immunoglobulins. Immunol Rev. 2005;206:64\u201382.","journal-title":"Immunol Rev"},{"key":"1829_CR17","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1006\/clim.2002.5241","volume":"104","author":"A Plebani","year":"2002","unstructured":"Plebani A, Soresina A, Rondelli R, Amato GM, Azzari C, Cardinale F, et al. Clinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: an Italian multicenter study. Clin Immunol. 2002;104:221\u201330.","journal-title":"Clin Immunol"},{"key":"1829_CR18","first-page":"1570","volume":"112","author":"TW LeBien","year":"2008","unstructured":"LeBien TW, Tedder TF. B lymphocytes: how they develop and function. Am Soc Hematol. 2008;112:1570\u201380.","journal-title":"Am Soc Hematol"},{"key":"1829_CR19","first-page":"9","volume":"8222","author":"RW Hendriks","year":"2011","unstructured":"Hendriks RW, Bredius RG, Pike-Overzet K, Staal FJ. Biology and novel treatment options for XLA, the most common monogenetic immunodeficiency in man. Expert Opin Ther Targets. 2011;8222:9\u201318.","journal-title":"Expert Opin Ther Targets"},{"key":"1829_CR20","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.3389\/fimmu.2017.01454","volume":"8","author":"ANR Weber","year":"2017","unstructured":"Weber ANR, Bittner Z, Liu X, Dang T-M, Radsak MP, Brunner C. Bruton\u2019s tyrosine kinase: an emerging Key Player in Innate Immunity. Front Immunol. 2017;8:1454. https:\/\/doi.org\/10.3389\/fimmu.2017.01454.","journal-title":"Front Immunol"},{"key":"1829_CR21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jaci.2011.01.052","volume":"128","author":"N Nakagawa","year":"2011","unstructured":"Nakagawa N, Imai K, Kanegane H, Sato H, Yamada M, Kondoh K, et al. Quantification of k-deleting recombination excision circles in Guthrie cards for the identification of early B-cell maturation defects. J Allergy Clin Immunol. 2011;128:223\u20135.","journal-title":"J Allergy Clin Immunol"},{"key":"1829_CR22","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1006\/clim.1999.4799","volume":"93","author":"ME Conley","year":"1999","unstructured":"Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Clin Immunol. 1999;93:190\u20137.","journal-title":"Clin Immunol"},{"key":"1829_CR23","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1007\/s10875-016-0284-3","volume":"36","author":"BA Bryan","year":"2016","unstructured":"Bryan BA, Battersby A, Shillitoe BMJ, Barge D, Bourne H, Flood T, et al. Respiratory Health and Related Quality of Life in patients with congenital agammaglobulinemia in the Northern Region of the UK. J Clin Immunol. 2016;36:472\u20139.","journal-title":"J Clin Immunol"},{"key":"1829_CR24","doi-asserted-by":"publisher","first-page":"A182","DOI":"10.1136\/thoraxjnl-2012-202678.039","volume":"67","author":"S Lum","year":"2012","unstructured":"Lum S, Bonner R, Kirkby J, Sonnappa S, Stocks J. S33 validation of the GLI-2012 multi-ethnic spirometry reference equations in London School Children. Thorax. 2012;67:A182\u201318.","journal-title":"Thorax"},{"key":"1829_CR25","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1111\/j.1440-1843.2012.02232.x","volume":"17","author":"GL Hall","year":"2012","unstructured":"Hall GL, Thompson BR, Stanojevic S, Abramson MJ, Beasley R, Coates A, et al. The global lung Initiative 2012 reference values reflect contemporary Australasian spirometry. Respirology. 2012;17:1150\u20131.","journal-title":"Respirology"},{"key":"1829_CR26","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1007\/s10875-021-01088-2","volume":"41","author":"BMJ Shillitoe","year":"2021","unstructured":"Shillitoe BMJ, Ponsford M, Slatter MA, Evans J, Struik S, Cosgrove M, et al. Haematopoietic stem cell transplant for Norovirus-Induced Intestinal failure in X-linked agammaglobulinemia. J Clin Immunol. 2021;41:1574\u201381.","journal-title":"J Clin Immunol"},{"key":"1829_CR27","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1093\/infdis\/jiw497","volume":"215","author":"B Kempf","year":"2017","unstructured":"Kempf B, Edgar JD, Mc Caughey C, Devlin LA. Nitazoxanide is an ineffective treatment of chronic norovirus in patients with X-Linked agammaglobulinemia and May yield false-negative polymerase chain reaction findings in stool specimens. J Infect Dis. 2017;215:486\u20137.","journal-title":"J Infect Dis"},{"key":"1829_CR28","first-page":"31","volume":"86","author":"R Hermaszewski","year":"1993","unstructured":"Hermaszewski R, Webster A. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med. 1993;86:31\u201342.","journal-title":"Q J Med"},{"key":"1829_CR29","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10875-009-9341-5","volume":"30","author":"PPW Lee","year":"2010","unstructured":"Lee PPW, Chen TX, Jiang LP, Chan KW, Yang W, Lee BW, et al. Clinical characteristics and genotype-phenotype correlation in 62 patients with X-linked agammaglobulinemia. J Clin Immunol. 2010;30:121\u201331.","journal-title":"J Clin Immunol"},{"key":"1829_CR30","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1084\/jem.147.6.1832","volume":"147","author":"SS Crago","year":"1978","unstructured":"Crago SS, Kulhavy R, Prince SJ, Mestecky J. Secretory component of epithelial cells is a surface receptor for polymeric immunoglobulins. J Exp Med. 1978;147:1832\u20137.","journal-title":"J Exp Med"},{"key":"1829_CR31","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1183\/09031936.01.00228801","volume":"18","author":"C Pilette","year":"2001","unstructured":"Pilette C, Ouadrhiri Y, Godding V, Vaerman JP, Sibille Y. Lung mucosal immunity: Immunoglobulin-A revisited. Eur Respir J. 2001;18:571\u201388.","journal-title":"Eur Respir J"},{"key":"1829_CR32","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.jaip.2020.08.016","volume":"9","author":"MJ Ponsford","year":"2021","unstructured":"Ponsford MJ, Price C, Farewell D, Greene G, Moore C, Perry M, et al. Increased respiratory viral detection and Symptom Burden among patients with primary antibody Deficiency: results from the BIPAD Study. J Allergy Clin Immunol Pract. 2021;9:735\u2013e7446.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1829_CR33","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.clnu.2012.06.002","volume":"32","author":"G Olveira","year":"2013","unstructured":"Olveira G, Olveira C, Dorado A, Garc\u00eda-Fuentes E, Rubio E, Tinahones F, et al. Cellular and plasma oxidative stress biomarkers are raised in adults with bronchiectasis. Clin Nutr. 2013;32:112\u20137.","journal-title":"Clin Nutr"},{"key":"1829_CR34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1089\/ped.2010.0010","volume":"23","author":"RP Guillerman","year":"2010","unstructured":"Guillerman RP. Imaging of Childhood interstitial lung disease. Pediatr Allergy Immunol Pulmonol. 2010;23:43\u201368.","journal-title":"Pediatr Allergy Immunol Pulmonol"},{"key":"1829_CR35","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jaci.2021.05.028","volume":"149","author":"CJ Nunes-Santos","year":"2022","unstructured":"Nunes-Santos CJ, Koh C, Rai A, Sacco K, Marciano BE, Kleiner DE, et al. Nodular regenerative hyperplasia in X-linked agammaglobulinemia: an underestimated and severe complication. J Allergy Clin Immunol. 2022;149:400\u2013e4093.","journal-title":"J Allergy Clin Immunol"},{"key":"1829_CR36","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1385\/CRIAI:19:2:183","volume":"19","author":"ME Conley","year":"2000","unstructured":"Conley ME, Rohrer J, Minegishi Y. X-linked agammaglobulinemia. Clin Rev Allergy Immunol. 2000;19:183\u2013204.","journal-title":"Clin Rev Allergy Immunol"},{"key":"1829_CR37","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/ni.2234","volume":"13","author":"F Honda","year":"2012","unstructured":"Honda F, Kano H, Kanegane H, Nonoyama S, Kim E, Lee S-K, et al. The kinase btk negatively regulates the production of reactive oxygen species and stimulation-induced apoptosis in human neutrophils. Nat Immunol. 2012;13:369\u201378.","journal-title":"Nat Immunol"},{"key":"1829_CR38","doi-asserted-by":"publisher","first-page":"23769","DOI":"10.1074\/jbc.M112.372425","volume":"287","author":"Y Bao","year":"2012","unstructured":"Bao Y, Zheng J, Han C, Jin J, Han H, Liu Y, et al. Tyrosine kinase btk is required for NK cell activation. J Biol Chem. 2012;287:23769\u201378.","journal-title":"J Biol Chem"},{"key":"1829_CR39","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1615\/CritRevImmunol.v29.i4.30","volume":"29","author":"AD Koprulu","year":"2009","unstructured":"Koprulu AD, Ellmeier W. The role of Tec family kinases in mononuclear phagocytes. Crit Rev Immunol. 2009;29:317\u201333.","journal-title":"Crit Rev Immunol"},{"key":"1829_CR40","doi-asserted-by":"crossref","unstructured":"Hernandez-Trujillo VP, Scalchunes C, Cunningham-Rundles C, Ochs HD, Bonilla F a., Paris K et al. Autoimmunity and inflammation in X-linked agammaglobulinemia. J Clin Immunol. 2014;34:627\u201332.","DOI":"10.1007\/s10875-014-0056-x"},{"key":"1829_CR41","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s10875-017-0374-x","volume":"37","author":"S Barmettler","year":"2017","unstructured":"Barmettler S, Otani IM, Minhas J, Abraham RS, Chang Y, Dorsey MJ, et al. Gastrointestinal manifestations in X-linked agammaglobulinemia. J Clin Immunol. 2017;37:287\u201394.","journal-title":"J Clin Immunol"},{"issue":"2","key":"1829_CR42","first-page":"190","volume":"75","author":"YL Lau","year":"1989","unstructured":"Lau YL, Shields JG, Levinsky RJ, Callard RE. Epstein-Barr-virus-transformed lymphoblastoid cell lines derived from patients with X-linked agammaglobulinaemia and Wiskott-Aldrich syndrome: responses to B cell growth and differentiation factors. Clin Exp Immunol. 1989;75(2):190.","journal-title":"Clin Exp Immunol"},{"key":"1829_CR43","doi-asserted-by":"publisher","first-page":"129","DOI":"10.18176\/jiaci.0129","volume":"27","author":"M Mu\u00f1oz-Miguelsanz","year":"2017","unstructured":"Mu\u00f1oz-Miguelsanz M, \u00c1lvarez Morales T, Mart\u00edn Garc\u00eda J, Mart\u00ednez Gallo M, Santos P\u00e9rez J. Pseudomonas aeruginosa Liver Abscess as the First Manifestation of X-Linked agammaglobulinemia with a Novel mutation. J Investig Allergol Clin Immunol. 2017;27:129\u201331.","journal-title":"J Investig Allergol Clin Immunol"},{"key":"1829_CR44","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1007\/s10875-023-01502-x","volume":"43","author":"V Hernandez-Trujillo","year":"2023","unstructured":"Hernandez-Trujillo V, Zhou C, Scalchunes C, Ochs HD, Sullivan KE, Cunningham-Rundles C, et al. A Registry Study of 240 patients with X-Linked agammaglobulinemia living in the USA. J Clin Immunol. 2023;43:1468\u201377.","journal-title":"J Clin Immunol"},{"key":"1829_CR45","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/cei.13068","volume":"191","author":"A Stubbs","year":"2018","unstructured":"Stubbs A, Bangs C, Shillitoe B, Edgar JD, Burns SO, Thomas M, et al. Bronchiectasis and deteriorating lung function in agammaglobulinaemia despite immunoglobulin replacement therapy. Clin Exp Immunol. 2018;191:212\u20139.","journal-title":"Clin Exp Immunol"},{"key":"1829_CR46","doi-asserted-by":"crossref","unstructured":"Nishimura A, Uppuluri R, Raj R, et al. An InternationalSurvey of Allogeneic Hematopoietic Cell Transplantation for X-LinkedAgammaglobulinemia. J >ClinImmunol. 2023;43(8):1827-1839.","DOI":"10.1007\/s10875-023-01551-2"},{"key":"1829_CR47","doi-asserted-by":"crossref","unstructured":"Vonarburg C, Loetscher M, Spycher MO, Kropf A, Illi M, Salmon S et al. Topical application of nebulized human IgG, IgA and IgAM in the lungs of rats and non-human primates. Respir Res. 2019;20.","DOI":"10.1186\/s12931-019-1057-3"},{"key":"1829_CR48","unstructured":"Stephan W, Dichtelm\u00fcller H, Schedel I. Properties and efficacy of a human immunoglobulin M preparation for intravenous administration. Arzneimittelforschung."},{"key":"1829_CR49","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s00134-018-5143-7","volume":"44","author":"T Welte","year":"2018","unstructured":"Welte T, Dellinger RP, Ebelt H, Ferrer M, Opal SM, Singer M, et al. Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study). Intensive Care Med. 2018;44:438\u201348.","journal-title":"Intensive Care Med"},{"key":"1829_CR50","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11882-014-0510-0","volume":"15","author":"B Bestas","year":"2015","unstructured":"Bestas B, Turunen JJ, Blomberg KEM, Wang Q, M\u00e5nsson R, Andaloussi EL. Splice-correction strategies for treatment of X-Linked agammaglobulinemia. Curr Allergy Asthma Rep. 2015;15:4.","journal-title":"Curr Allergy Asthma Rep"},{"key":"1829_CR51","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.1172\/JCI76175","volume":"124","author":"B Bestas","year":"2014","unstructured":"Bestas B, Moreno PMD, Blomberg KEM, Mohammad DK, Saleh AF, Sutlu T, et al. Splice-correcting oligonucleotides restore BTK function in X-linked agammaglobulinemia model. J Clin Invest. 2014;124:4067\u201381.","journal-title":"J Clin Invest"},{"key":"1829_CR52","doi-asserted-by":"crossref","unstructured":"Yamamoto H, Ishimura M, Ochiai M, Takada H, Kusuhara K, Nakatsu Y, et al. BTK gene targeting by homologous recombination using a helper-dependent adenovirus\/adeno-associated virus hybrid vector. Vol. 23. Nature Publishing Group; 2016.","DOI":"10.1038\/gt.2015.91"},{"key":"1829_CR53","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/gt.2008.17","volume":"15","author":"T Moreau","year":"2008","unstructured":"Moreau T, Barlogis V, Bardin F, Nunes Ja, Calmels B, Chabannon C, et al. Development of an enhanced B-specific lentiviral vector expressing BTK: a tool for gene therapy of XLA. Gene Ther. 2008;15:942\u201352.","journal-title":"Gene Ther"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-024-01829-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-024-01829-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-024-01829-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T17:03:08Z","timestamp":1777309388000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-024-01829-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,14]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1829"],"URL":"https:\/\/doi.org\/10.1007\/s10875-024-01829-z","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,14]]},"assertion":[{"value":"15 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ben Shillitoe has received travel grants from Pharming and speaker fees from TakedaTomaz Garcez has Consulting, advisory work and educational support from BioCryst, CSL Behring, KalVista, Novartis, Octapharma, Pharming and Takeda.Jaime S Rosa Duque received a conference sponsorship from Merck Sharp & Dohme in 2023Yu Lung Lau chairs the Scientific Committee on Vaccine Preventable Diseases of the Hong Kong Government. The remaining authors have no COIs to delcare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"40"}}